Sanofi Adr Stock Buy Hold or Sell Recommendation
| SNY Stock | USD 46.61 1.08 2.26% |
Considering the 90-day investment horizon and your way above-average risk tolerance, our recommendation regarding Sanofi ADR is 'Hold'. Macroaxis provides Sanofi ADR buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SNY positions. The advice algorithm takes into account all of Sanofi ADR's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Sanofi ADR's buy or sell advice are summarized below:
Real Value 56.17 | Target Price 65.13 | Hype Value 46.59 | Market Value 46.61 | Naive Value 46.89 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Sanofi ADR given historical horizon and risk tolerance towards Sanofi ADR. When Macroaxis issues a 'buy' or 'sell' recommendation for Sanofi ADR, the advice is generated through an automated system that utilizes algorithms and statistical models.
Sanofi |
Execute Sanofi ADR Buy or Sell Advice
The Sanofi recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sanofi ADR. Macroaxis does not own or have any residual interests in Sanofi ADR or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sanofi ADR's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Sanofi ADR Trading Alerts and Improvement Suggestions
| Sanofi ADR generated a negative expected return over the last 90 days | |
| Sanofi ADR has a strong financial position based on the latest SEC filings | |
| Latest headline from finance.yahoo.com: Regeneron commits 500M to new venture capital fund |
Sanofi ADR Returns Distribution Density
The distribution of Sanofi ADR's historical returns is an attempt to chart the uncertainty of Sanofi ADR's future price movements. The chart of the probability distribution of Sanofi ADR daily returns describes the distribution of returns around its average expected value. We use Sanofi ADR price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sanofi ADR returns is essential to provide solid investment advice for Sanofi ADR.
| Mean Return | -0.1 | Value At Risk | -1.85 | Potential Upside | 2.00 | Standard Deviation | 1.10 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sanofi ADR historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sanofi Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sanofi ADR is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sanofi ADR backward and forwards among themselves. Sanofi ADR's institutional investor refers to the entity that pools money to purchase Sanofi ADR's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Mondrian Investment Partners Ltd | 2023-12-31 | 2.8 M | Envestnet Asset Management Inc | 2023-12-31 | 2.6 M | Natixis Advisors, Llc. | 2023-12-31 | 2.5 M | Hotchkis & Wiley Capital Management Llc | 2023-12-31 | 2.3 M | Wells Fargo & Co | 2023-12-31 | 2.3 M | Pictet Asset Manangement Sa | 2023-12-31 | 2.1 M | Royal Bank Of Canada | 2023-12-31 | 2 M | Equity Investment Corp | 2023-12-31 | 1.9 M | Raymond James & Associates | 2023-12-31 | 1.8 M | Dodge & Cox | 2023-12-31 | 78.3 M | Fmr Inc | 2023-12-31 | 20.4 M |
Sanofi ADR Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (547M) | (593M) | (357M) | (927M) | (840M) | (798M) | |
| Change In Cash | 2.5B | 4.5B | (3.8B) | 2.6B | (4.0B) | (3.8B) | |
| Free Cash Flow | 5.9B | 5.3B | 8.5B | 8.3B | 7.0B | 5.6B | |
| Depreciation | 7.4B | 3.7B | 3.4B | 3.4B | 3.8B | 4.1B | |
| Other Non Cash Items | (293M) | (8.0B) | (105M) | 20M | 9.7B | 10.2B | |
| Dividends Paid | 3.8B | 3.9B | 4.0B | 4.2B | 4.5B | 2.9B | |
| Net Income | 2.8B | 12.3B | 6.2B | 8.4B | 5.4B | 4.6B | |
| End Period Cash Flow | 9.4B | 13.9B | 10.1B | 12.7B | 8.7B | 6.7B | |
| Investments | (1.1B) | 10.2B | (311M) | (2.1B) | (6.2B) | (5.9B) | |
| Net Borrowings | (491M) | (1.9B) | (2.8B) | (1.2B) | (1.1B) | (1.1B) | |
| Change To Netincome | 1.6B | (7.9B) | (230M) | (600M) | (540M) | (567M) |
Sanofi ADR Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sanofi ADR or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sanofi ADR's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sanofi stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.13 | |
β | Beta against NYSE Composite | 0.31 | |
σ | Overall volatility | 1.15 | |
Ir | Information ratio | -0.17 |
Sanofi ADR Volatility Alert
Sanofi ADR exhibits very low volatility with skewness of 0.21 and kurtosis of 0.54. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Sanofi ADR's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Sanofi ADR's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Sanofi ADR Fundamentals Vs Peers
Comparing Sanofi ADR's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sanofi ADR's direct or indirect competition across all of the common fundamentals between Sanofi ADR and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sanofi ADR or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sanofi ADR's fundamental indicators could also be used in its relative valuation, which is a method of valuing Sanofi ADR by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Sanofi ADR to competition |
| Fundamentals | Sanofi ADR | Peer Average |
| Return On Equity | 0.0727 | -0.31 |
| Return On Asset | 0.0454 | -0.14 |
| Profit Margin | 0.12 % | (1.27) % |
| Operating Margin | 0.07 % | (5.51) % |
| Current Valuation | 69.57 B | 16.62 B |
| Shares Outstanding | 2.5 B | 571.82 M |
| Shares Owned By Institutions | 9.95 % | 39.21 % |
| Number Of Shares Shorted | 3.9 M | 4.71 M |
| Price To Earning | 7.78 X | 28.72 X |
| Price To Book | 1.44 X | 9.51 X |
| Price To Sales | 2.52 X | 11.42 X |
| Revenue | 43.07 B | 9.43 B |
| Gross Profit | 31.7 B | 27.38 B |
| EBITDA | 12.96 B | 3.9 B |
| Net Income | 5.4 B | 570.98 M |
| Cash And Equivalents | 6.9 B | 2.7 B |
| Cash Per Share | 2.76 X | 5.01 X |
| Total Debt | 18.42 B | 5.32 B |
| Debt To Equity | 0.30 % | 48.70 % |
| Current Ratio | 1.30 X | 2.16 X |
| Book Value Per Share | 59.17 X | 1.93 K |
| Cash Flow From Operations | 10.26 B | 971.22 M |
| Short Ratio | 2.34 X | 4.00 X |
| Earnings Per Share | 2.29 X | 3.12 X |
| Price To Earnings To Growth | 0.84 X | 4.89 X |
| Target Price | 59.12 | |
| Number Of Employees | 86.09 K | 18.84 K |
| Beta | 0.45 | -0.15 |
| Market Capitalization | 119.06 B | 19.03 B |
| Total Asset | 126.46 B | 29.47 B |
| Retained Earnings | 67.5 B | 9.33 B |
| Working Capital | 6.46 B | 1.48 B |
| Current Asset | 24.93 B | 9.34 B |
Sanofi ADR Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sanofi . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Sanofi ADR Buy or Sell Advice
When is the right time to buy or sell Sanofi ADR? Buying financial instruments such as Sanofi Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 22.4B | 21.2B | 18.4B | 13.7B | Total Assets | 120.2B | 124.6B | 126.5B | 88.2B |
Use Investing Ideas to Build Portfolios
In addition to having Sanofi ADR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Sanofi ADR Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Sanofi Stock analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.217 | Dividend Share 3.76 | Earnings Share 2.29 | Revenue Per Share 18.388 | Quarterly Revenue Growth 0.029 |
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.